Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lenalidomide-Br (Compound 41) is a derivative of Lenalidomide, which serves as a ligand for cereblon (CRBN) - an E3 ubiquitin ligase involved in protein recruitment. This compound, Lenalidomide-Br, can be conjugated to a protein ligand through a linker to create PROTACs. For instance, Lenalidomide-Br is utilized as a component in the PROTAC STAT3 degrader SD-36.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 50.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Lenalidomide-Br (Compound 41) is a derivative of Lenalidomide, which serves as a ligand for cereblon (CRBN) - an E3 ubiquitin ligase involved in protein recruitment. This compound, Lenalidomide-Br, can be conjugated to a protein ligand through a linker to create PROTACs. For instance, Lenalidomide-Br is utilized as a component in the PROTAC STAT3 degrader SD-36. |
In vitro | Lenalidomide-Br can be conjugated to a protein ligand via a linker, forming PROTACs that induce the ubiquitination-mediated degradation of oncogenic proteins. |
In vivo | Lenalidomide-Br can form a PROTAC by coupling with a protein's ligand. PROTAC acts as an inducer of ubiquitin-mediated degradation of oncogenic proteins [1][2]. |
Molecular Weight | 323.14 |
Formula | C13H11BrN2O3 |
CAS No. | 2093387-36-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (92.84 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lenalidomide-Br 2093387-36-9 PROTAC Ligand for E3 Ligase Ligands for E3 Ligase analog Inhibitor recruitment ubiquitin inhibit LenalidomideBr E3 ligase-recruiting Moiety cereblon Lenalidomide Br ligase protein inhibitor